J T Lichtenhan1, J Hartsock2, J R Dornhoffer3, K M Donovan4, A N Salt2. 1. Washington University School of Medicine, Department of Otolaryngology, Saint Louis, MO 63110, USA. Electronic address: LichtenhanJ@ent.wustl.edu. 2. Washington University School of Medicine, Department of Otolaryngology, Saint Louis, MO 63110, USA. 3. University of Arkansas School of Medicine, Little Rock, AR 72205, USA. 4. Program in Audiology and Communication Sciences, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Abstract
BACKGROUND: Administering pharmaceuticals to the scala tympani of the inner ear is a common approach to study cochlear physiology and mechanics. We present here a novel method for in vivo drug delivery in a controlled manner to sealed ears. NEW METHOD: Injections of ototoxic solutions were applied from a pipette sealed into a fenestra in the cochlear apex, progressively driving solutions along the length of scala tympani toward the cochlear aqueduct at the base. Drugs can be delivered rapidly or slowly. In this report we focus on slow delivery in which the injection rate is automatically adjusted to account for varying cross sectional area of the scala tympani, therefore driving a solution front at uniform rate. RESULTS: Objective measurements originating from finely spaced, low- to high-characteristic cochlear frequency places were sequentially affected. Comparison with existing methods(s): Controlled administration of pharmaceuticals into the cochlear apex overcomes a number of serious limitations of previously established methods such as cochlear perfusions with an injection pipette in the cochlear base: The drug concentration achieved is more precisely controlled, drug concentrations remain in scala tympani and are not rapidly washed out by cerebrospinal fluid flow, and the entire length of the cochlear spiral can be treated quickly or slowly with time. CONCLUSIONS: Controlled administration of solutions into the cochlear apex can be a powerful approach to sequentially effect objective measurements originating from finely spaced cochlear regions and allows, for the first time, the spatial origin of CAPs to be objectively defined.
BACKGROUND: Administering pharmaceuticals to the scala tympani of the inner ear is a common approach to study cochlear physiology and mechanics. We present here a novel method for in vivo drug delivery in a controlled manner to sealed ears. NEW METHOD: Injections of ototoxic solutions were applied from a pipette sealed into a fenestra in the cochlear apex, progressively driving solutions along the length of scala tympani toward the cochlear aqueduct at the base. Drugs can be delivered rapidly or slowly. In this report we focus on slow delivery in which the injection rate is automatically adjusted to account for varying cross sectional area of the scala tympani, therefore driving a solution front at uniform rate. RESULTS: Objective measurements originating from finely spaced, low- to high-characteristic cochlear frequency places were sequentially affected. Comparison with existing methods(s): Controlled administration of pharmaceuticals into the cochlear apex overcomes a number of serious limitations of previously established methods such as cochlear perfusions with an injection pipette in the cochlear base: The drug concentration achieved is more precisely controlled, drug concentrations remain in scala tympani and are not rapidly washed out by cerebrospinal fluid flow, and the entire length of the cochlear spiral can be treated quickly or slowly with time. CONCLUSIONS: Controlled administration of solutions into the cochlear apex can be a powerful approach to sequentially effect objective measurements originating from finely spaced cochlear regions and allows, for the first time, the spatial origin of CAPs to be objectively defined.
Authors: Zhiqiang Chen; Sharon G Kujawa; Michael J McKenna; Jason O Fiering; Mark J Mescher; Jeffrey T Borenstein; Erin E Leary Swan; William F Sewell Journal: J Control Release Date: 2005-11-07 Impact factor: 9.776
Authors: Woo Seok Kang; Kim Nguyen; Charles E McKenna; William F Sewell; Michael J McKenna; David H Jung Journal: Otol Neurotol Date: 2016-07 Impact factor: 2.311
Authors: Alana E Kennedy; Wafaa A Kaf; John A Ferraro; Rafael E Delgado; Jeffery T Lichtenhan Journal: Front Neurosci Date: 2017-07-27 Impact factor: 4.677
Authors: Amit Walia; Choongheon Lee; Jared Hartsock; Shawn S Goodman; Roland Dolle; Alec N Salt; Jeffery T Lichtenhan; Mark A Rutherford Journal: Front Synaptic Neurosci Date: 2021-07-05
Authors: Jeffery T Lichtenhan; Choongheon Lee; Farah Dubaybo; Kaitlyn A Wenrich; Uzma S Wilson Journal: Front Neurosci Date: 2017-07-18 Impact factor: 4.677